中医诊治卵巢早衰的现代临床文献研究
|
摘要
目的系统分析研究现代文献对卵巢早衰病因病机的认识及证治、用药规律。
方法
运用文献学、统计学分析相结合的方法,分别建立病因病机、证治方药数据库,运用频数统计法,系统分析现代医家对卵巢早衰病因病机的认识及用药特点。对中医治疗本病的高频药物进行研究和整理,从中组合出治疗本病的基本方药。结果
所有病因病机中肾虚精亏所占比例最大,为23.23%,中药出现总体频次为927味次,其中补益药532味次,占57.39%,居于首位；居第二、第三位的分别为活血化瘀药147味次,占15.86%,清热泻火药57味次,占6.15%。按统计学析方原则,若将高频药物中累积频率超过50%的药物味次累积相加,合为一剂,则方药组成为当归、熟地、菟丝子、枸杞子、仙灵脾、白芍。
结论
1.卵巢早衰的病因病机：肾肝脾心功能失调是根本病机,其中肾虚是发病的基础；肝脾心功能失调与肾虚互为因果；气虚血瘀是发病的重要环节。肾虚精亏是最根本病机。
2.治疗卵巢早衰的基本思路与方法：①调整脏腑功能,为补肾为主,佐以健脾养心、调肝泻火；②治病求本,标本兼治,活血化瘀是常用的治标之法；③中药分期论治,建立自然周期；④中西医结合是有效治疗手段；⑤身心同治,提高疗效；⑥积极预防,减少发病。
3.现代医家治疗卵巢早衰的基本药物组合为当归、熟地、菟丝子、枸杞子、仙灵脾、白芍。
Objective
The study intends to systematically analyze the etiopathogenisis, etiology, the differentiation, treatment and medication laws about premature ovarian failure (POF) that were discussed in modern literature. Methods
Adopting the bibliography and statistics methods together, the author establishes the pathogenesis, the differentiation, treatment and medication databases. With pykno-statistical methods, the author systematically analyzes modern physicians'understanding about POF and their medication features. The author studies and sorts out the high-frequency medications on POF and finds out the basic prescriptions and medicine for POF treatment.
Results
Renal deficiency and essence deficiency occupies the largest proportion of all pathogenesis and etiology, i.e.23.23%.927 kinds of Chinese Herbal Medicine are used, among which 532 are tonics, occupying 57.39% and ranking the first place; 147 are drugs for invigorating blood circulation and eliminating stasis, occupying 15.86% and ranking the second; 57 are heat-clearing and fire-purging drugs, occupying 6.15% and ranking the third. According to the prescription analysis principles in statistics, if the drugs with accumulated frequency above 50% are combined to be one dosis, then the prescription should be angelica, prepared rhizome of rehmannia, cuscuta seed, fructus lycii, herba epimedii and radix paeoniae alba.
Conclusion
1. Pathogenesis and etiology of POF:dysfunction of kidney, liver, spleen and heart is the fundamental etiology, among which renal deficiency is the foundation; the dysfunction of liver, spleen and heart and the deficiency of kidney are mutual causes and results; qi deficiency and blood stasis is the important pathogenetic cause. Renal deficiency and essence deficiency are the most basic etiology.
2. Basic thoughts and methods for POF treatment:①Adjust zang and fu organs' function. Take invigorating the kidney as the major method and replenishing spleen and heart, adjusting liver and clearing pathogenic fire as the complementary method.②Cure the root of disease and take care of the appearance and substance a the same time. Invigorating blood and dissolving stasis is the common method.③Treat POF with Chinese Herbal Medicine by different stages and establish the natural cycles.④Combining Chinese Medicine and Western Medicine together to treat POF is the effective way.⑤Treat physically and psychologically to improve the efficacy.⑥Active prevention may reduce the incidence of diseases.
3. The basic medication combination adopted by modern physicians to treat POF are angelica, prepared rhizome of rehmannia, cuscuta seed, barbary wolfberry fruit, herba epimedii and radix paeoniae alba.
方法
运用文献学、统计学分析相结合的方法,分别建立病因病机、证治方药数据库,运用频数统计法,系统分析现代医家对卵巢早衰病因病机的认识及用药特点。对中医治疗本病的高频药物进行研究和整理,从中组合出治疗本病的基本方药。结果
所有病因病机中肾虚精亏所占比例最大,为23.23%,中药出现总体频次为927味次,其中补益药532味次,占57.39%,居于首位；居第二、第三位的分别为活血化瘀药147味次,占15.86%,清热泻火药57味次,占6.15%。按统计学析方原则,若将高频药物中累积频率超过50%的药物味次累积相加,合为一剂,则方药组成为当归、熟地、菟丝子、枸杞子、仙灵脾、白芍。
结论
1.卵巢早衰的病因病机：肾肝脾心功能失调是根本病机,其中肾虚是发病的基础；肝脾心功能失调与肾虚互为因果；气虚血瘀是发病的重要环节。肾虚精亏是最根本病机。
2.治疗卵巢早衰的基本思路与方法：①调整脏腑功能,为补肾为主,佐以健脾养心、调肝泻火；②治病求本,标本兼治,活血化瘀是常用的治标之法；③中药分期论治,建立自然周期；④中西医结合是有效治疗手段；⑤身心同治,提高疗效；⑥积极预防,减少发病。
3.现代医家治疗卵巢早衰的基本药物组合为当归、熟地、菟丝子、枸杞子、仙灵脾、白芍。
Objective
The study intends to systematically analyze the etiopathogenisis, etiology, the differentiation, treatment and medication laws about premature ovarian failure (POF) that were discussed in modern literature. Methods
Adopting the bibliography and statistics methods together, the author establishes the pathogenesis, the differentiation, treatment and medication databases. With pykno-statistical methods, the author systematically analyzes modern physicians'understanding about POF and their medication features. The author studies and sorts out the high-frequency medications on POF and finds out the basic prescriptions and medicine for POF treatment.
Results
Renal deficiency and essence deficiency occupies the largest proportion of all pathogenesis and etiology, i.e.23.23%.927 kinds of Chinese Herbal Medicine are used, among which 532 are tonics, occupying 57.39% and ranking the first place; 147 are drugs for invigorating blood circulation and eliminating stasis, occupying 15.86% and ranking the second; 57 are heat-clearing and fire-purging drugs, occupying 6.15% and ranking the third. According to the prescription analysis principles in statistics, if the drugs with accumulated frequency above 50% are combined to be one dosis, then the prescription should be angelica, prepared rhizome of rehmannia, cuscuta seed, fructus lycii, herba epimedii and radix paeoniae alba.
Conclusion
1. Pathogenesis and etiology of POF:dysfunction of kidney, liver, spleen and heart is the fundamental etiology, among which renal deficiency is the foundation; the dysfunction of liver, spleen and heart and the deficiency of kidney are mutual causes and results; qi deficiency and blood stasis is the important pathogenetic cause. Renal deficiency and essence deficiency are the most basic etiology.
2. Basic thoughts and methods for POF treatment:①Adjust zang and fu organs' function. Take invigorating the kidney as the major method and replenishing spleen and heart, adjusting liver and clearing pathogenic fire as the complementary method.②Cure the root of disease and take care of the appearance and substance a the same time. Invigorating blood and dissolving stasis is the common method.③Treat POF with Chinese Herbal Medicine by different stages and establish the natural cycles.④Combining Chinese Medicine and Western Medicine together to treat POF is the effective way.⑤Treat physically and psychologically to improve the efficacy.⑥Active prevention may reduce the incidence of diseases.
3. The basic medication combination adopted by modern physicians to treat POF are angelica, prepared rhizome of rehmannia, cuscuta seed, barbary wolfberry fruit, herba epimedii and radix paeoniae alba.
引文
[1]刘敏如,欧阳惠卿.实用中医妇科学[M].第2版.上海：上海科学技术出版社,2010：242-245.
[2]杨业洲,韩字研.卵巢早衰的防治原则[J].实用妇产科杂志,2003,4(19)：201-203.
[3]Hofmann GE. Danforth DR. Seifer DB[J]. Fertil Steril.1998,69(3):474.
[4]Zheng W, Magid MS, Kramer EE. Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube[J]. Am J Pathol,1996,148:47.
[5]王菊素.田淑霄教授对卵巢早衰与肾虚血瘀相关性的见解及治疗经验[J].陕西中医,2003,24(11)：10-15.
[6]李艳石,王禹.王秀云教授治疗卵巢早衰经验拾萃[J].中医药学刊,2005,23(1)：31.
[7]邢翠玲,杨玉荣.中西医结合治疗卵巢早衰310例[J].国医论坛,1995,10(3)：20.
[8]许昕.补肾养血调经法治疗有卵泡型卵巢早衰[J].北京中医,2001,(4)：21.
[9]沈慰,俞超芹.从肾论治卵巢早衰[J].中西医结合学报,2006,11(4)：653.
[10]梁静雅.连方教授治疗卵巢早衰性不孕经验[J].四川中医,2010,28(11)：14-15.
[11]马景,何嘉琳.何嘉琳治疗卵巢早衰的临床经验[J].浙江中医杂志,2009,44(4)：260-261.
[12]黄健萍.卵巢早衰的中医治疗述要[J].辽宁中医学院学报,2004,6(2)：126.
[13]蔡立荣.补肾活血方对小鼠实验性卵巢早衰防治作用的研究[J].中国中西医结合杂志,2001,21(2)：126.
[14]钱海墨,范晓艳,陈颖异.陈颖异治疗卵巢早衰经验[J].中医杂志,2009,50(5)：402-403.
[15]施艳秋.乌鳖口服液治疗卵巢功能早衰的临床与实验研究总结[J].中华实用中西医杂志,2004,17(4)：425.
[16]史云,蔡平平,邓高丕.张玉珍教授治疗卵巢早衰经验介绍[J].新中医,2006,38(9)：15.
[17]庞震苗,熊学军.张玉珍治疗卵巢早衰验案举隅[J].辽宁中医杂志,2006,33(10)：1348.
[18]王芳,张丽君.卵巢早衰的病因病机及辨证治疗概况[J].江西中医药,2007,38(10)：70.
[19]兰英,柴巍.柴瑞霭治疗卵巢早衰验案举隅[J].山西中医,2001,17(4)：5.
[20]夏天.卵巢早衰的中西医结合研究进展[J].辽宁中医杂志,2004,33(8)：707.
[21]张朝辉,张亚辉.阳和汤治疗卵巢早衰症治验[J].北京中医,2001,17(4)：16.
[22]陈秀芳.辨证治疗卵巢早衰22例[J].四川中医,2000,18(1)：35.
[23]朱玲,罗颂平.卵巢早衰的病因病机及其证治[J].中医药学刊,2003,21(1)：143.
[24]徐萍.巢衰汤治疗卵巢早衰31例报告[J].甘肃中医,2003,16(6)：31.
[25]胡向丹,李丽芸.李丽芸教授治疗卵巢早衰的经验撷要[J].新中医,2010,42(7)：127-128.
[26]滕秀香.122例卵巢早衰患者中医证候分析及致病因素调查[J].中国中医药信息杂志,2008,15(4)：18-20.
[27]姚石安.卵巢早衰中医证治需注意哪些方面[J].中医杂志,1998,39(5)：313.
[28]杨兰英.六味地黄丸治疗卵巢早衰的实验研究[J].山西中医学院学报,2002,3(1)：21-23.
[29]张立.卵巢早衰36例分析及其治疗[J].中医药学刊,2003,21(4)：619.
[30]温鸿雁,范智斌.卵巢早衰的中西医研究近况[J].中医药研究,2001,17(6)：49.
[31]罗绍松.一贯煎加减治疗卵巢功能早衰38例疗效观察[J].贵阳中医学院学报,1998,20(4),19-20.
[32]周华,赵春梅.中西医治疗卵巢早衰临床研究述略[J].中医药学刊,2004,22(5)：903.
[33]杨利侠.卵巢早衰的中医药证治思路与方法[J].四川中医,2005,23(8)：11.
[34]李云君.姜惠中治疗卵巢早衰的经验[J].湖北中医杂志,2006,2(6)：28-29.
[35]李晨辉.中医治疗卵巢早衰50例[J].现代中西医结合杂志,2007,16(34)：5139-5140.
[36]胡道敏,吴克明.加减苁蓉菟丝子丸治疗卵巢早衰疗效分析[J].甘肃中医,2010,23(9)：43-44.
[37]周佩云,黄裕晓,吴伍香.蔡连香教授采用中药内服外用治疗卵巢早衰经验[J].中华中医药杂志,2010,25(10)：1613-1615.
[38]佟庆.柴松岩诊治卵巢早衰经验[J].北京中医药,2009,28(3)：196-197.
[39]伍娟娟.尤昭玲治卵巢早衰经验[J].江西中医药,2009,40(5)：27.
[40]杜晓萍,梅乾茵.梅乾茵治疗卵巢早衰经验[J].江西中医药,2008,39(10)：16-17.
[41]原迪.刘宇新教授益气生精法治疗卵巢早衰经验[J].现代中西医结合杂志,2009,18(18)：2188-2189.
[42]龙莉,韩延华.韩延华教授治疗卵巢早衰经验介绍[J].新中医,2008,40(8)：3.
[43]张蕾,曲秀芬.曲秀芬教授治疗卵巢早衰经验拾萃[J].杏林中医药,2009,29(7)：565-566.
[44]任洁宁,杨鉴冰.杨鉴冰教授治疗卵巢早衰用药经验介绍[J].现代中医药,2009,29(3)：1-2.
[45]杨鉴冰,侯秀环.归肾丸加减治疗卵巢早衰的临床观察[J].陕西中医学院学报,1995,18(37),24-25.
[46]李宗恒,钟雪梅,代加莉.雌激素顺序法与补经汤治疗卵巢早衰的比较观察[J].中国中医药科技,2002,9(3)：17.
[47]史云,张玉珍.补肾健脾调肝活血法治疗卵巢功能早衰临床观察[J].中医药学刊,2006,24(6)：1174-1176.
[48]刘枫林,许妙玲.黄果补血汤治疗卵巢功能早衰36例[J].云南中医药杂志,1997,18(1)：27-28.
[49]王璇.仙乐雄胶囊治疗卵巢早衰闭经47例临床观察[J].基层中药杂志,1999,13(4)：55.
[50]陈国姿,徐红.中药人工周期疗法治疗卵巢功能早衰继发性闭经32例[J].广东医学,1999,20(10)：782.
[51]高露露,谢亚莉.谢亚莉教授治疗卵巢早衰之经验[J].辽宁中医药大学学报,2009,11：100-102.
[52]庆璐,武淑慧.崔晓萍教授循期阴阳序贯治疗卵巢早衰经验总结[J].陕西中医学院学报,2010,33(5)：22-23.
[53]徐洁,蔡昱,谢群.卵巢早衰的中西医结合治疗与预防[J].中国当代医学,2005,4(7)：83.
[54]刑翠玲,杨玉荣.中西医结合治疗卵巢早衰310例[J].国医论坛,1995,10(3)：20.
[55]秦佳佳.中西医结合疗法治疗卵巢早衰72例临床观察[J].四川中医,2006,24(8)：86.
[56]衣忠玲.卵巢早衰治疗体会[J].实用中医药杂志,2000,16(9)：38.
[57]和平,张艳婷.中西医结合治疗卵巢早衰早期的临床探讨[J].云南中医中药杂志,2004,25(2)：3-4.
[58]许昕,腾秀香,佟庆.补肾养血调经法治疗有卵泡型卵巢早衰[J].北京中医,2001,(4)：21-22.
[59]Rabinovici J, Jarfe RB. Development and regulation of growth and differentiated funtion of human and subhuman primate fetal gonads[J]. Endocr Rev,1990,11:532.
[60]Baker TG. A quantitative and cytological study of germ cells in human ovaries[J]. Proc Roy Soc Lond,1963,158:417.
[61]Condos B, Bhiraleus P, Hobel C. Ultrastructural observations on germ cells in human fetal ovaries[J]. Am J Obstet Gynecol,1986,155:189.
[62]Ammini AC, Pandey J, Vijyaraghavan M, et al. Human female phenotypic development:role of fetal ovaries[J]. J Clin Endocrinol Metab,1994,79:604.
[63]Burger HG, Famada Y, Bangah ML. Serum gonadotropin, sex steroid, and immunoreactive inhibin levels in the first two years of life[J]. J Clin Endocrinol Metab,1991,72:682.
[64]Richardson S J, Senikas V, Nelson JF. Follicular depletion during the menopausal transition—evidence for accelerated loss and ultimate exhaustion[J]. J Clin Endocrinol Metab,1987,65:1231.
[65]Tilly JL, Kowalski KI, Schomberg DW. Apoptosis in atretic ovarian follicles is associated with selected decreases in messenger ribonucleic acid transcripts for gonadotropin receptors and cytochrome P450 aromatase[J]. Endocrinology,1992,131:1670.
[66]Dees WL, Hiney JK Schultea TD. The primate ovary contains a population of catecholaminergic neuron-like cells expressing nerve growth factor receptors[J]. Endocrinology,1995,136:5760.
[67]Peters H, Byskov AG, Himelstein. Follicular growth:the basic event in the mouse and human ovary[J]. J Reprod Fertil,1975,45:559.
[68]Gougeon A, Echochard R, Thalabard JC. Age-related changes of the population of human ovarian follicles:increase in the disappearance rate of non-growing and early-growing follicles in aging women[J]. Biol Reprod,1994,50:653.
[69]Mais v, Kazer RR, Cetel NS. The dependency of folliculogenesis and corpus luteum-function on pulsatile gonadotropin secretion in cycling women using a gonadotropin-releasing hormone antagonist as a probe[J]. J Clin Endocrinol Metab,1986,62:1250.
[70]Oktay K, Newton H, Mullan J. Development of human primordial follicles to antral stages in SCID/hpg mice stimulated with follicle stimulating hormone[J]. Hum Reprod,1998,13:1133.
[71]Schipper I, Hop WCJ, Fauser BCJM. The follicle-stimulating hormone threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development[J]. J Clin Endocrinol Metab,1998,83:1292.
[72]Oktay K, Briggs DA, Gosden RG. Ontogeny of follicle-stimulating hormone receptor gene expression in isolated human ovarian follicles[J]. J Clin Endocrinol Metab,1997,82:3748.
[73]Yong EL, Baird DT, Hillier SG. Mediation of gonadotropinstimulated growth and differentiation of human granulosa cells by adenosine-3',5-monophosphate:one molecule, two messages[J]. Clin Endocrinol,1992,37:51.
[74]LaPolt PS, Tilly JL, Aihara T. Gonadotropin-induced up and down regulation of ovarian follicle-stimulating hormone(FSH)receptor gene expression in immature rats:effects of pregnant mare's serum gonadotropin, human chorionic gonadotropin, and recombinant FSH[J]. Endocriw nology,1992,130:1289.
[75]Tilly JL, LaPolt PS, Hsueh AJ. Hormonal regulation of follicle-stimulating hormone receptor messenger ribonucleic acid levels in cultured rat granulosa cells[J]. Endocrinology,1992,130:1296.
[76]Hild-Petito S, West NB, Brenner RM. Localization of androgen receptor in the follicle and corpus luteum of the primate ovary during the menstrual cycle[J]. Biol Reprod,1991,44:561.
[77]Erickson GF, Magoffin DA, Dyer CA. The ovarian androgen producing cells: a review of structure/function relationships [J]. Endocr Rev,1985,6:371.
[78]Andersen CY, Characteristics of human follicular fluid associated with successful conception after in vitro fertilization[J]. J Clin Endocrinol Metab,1993,77:1227.
[79]Erickson GF, An analysis of follicle development and ovum maturation[J]. Seminars Reprod Endocrinol,1986,4:233.
[80]McNatty KP, Markris A, DeGraziak C. Steroidogenesis by recombined follicular cells from the human ovary in vitro[J]. J Clin Endocrinol Metab,1980,51:1286.
[81]McNatty KP, Smith DM, Makris A. The intraovarian sites of androgen and estrogen formation in women with normal and hyperandrogenic ovaries as judged by in vitro experiments [J]. J Clin Endocrinol Metab,1980,50:755.
[82]Hillier SG. Paracrine control of follicular estrogen synthesis[J]. Seminars Reprod Endocrinol,1991,9:332.
[83]Kobayashi M, Nakano R, Ooshima A. Immunohistochemical localization of pituitary gonadotropins and gonadal steroids confirms the two cells two gonadotropins hypothesis of steroidogenesis in the human ovary[J]. J Endocrinol,1990,126:483.
[84]Yamoto M, Shima'K, Nakano R. Gonadotropin receptors in human ovarian foil icles and corpora lutea throughout the menstrual cycle[J]. Hot Res,1992,37(Suppl 1):5.
[85]Magoffin DA. Regulation of differentiated functions in ovarian theca cells[J]. Seminars Reprod Endocrinol,1991,9:321.
[86]Sasano H, Okamoto M, Mason JI. Immunolocalization of aromatase 17ct-hydroxylase and side-chain-cleavage cyto-chromes P-450 in the human ovary[J]. J Reprod Fertil,1989,85:163.
[87]Rivier C, Rivier j,Vale W. Inhibin-mediated feedback control of follicle-stimulating hormone secretion in the female rat[J]. Science,1986,234:205.
[88]Bicsak TA, Tucker EM, Cappel S. Hormonal regulation of granulosa cell inhibin biosynthesis[J]. Endocrinology,1986,119:271.
[89]Xiao S, Robertson DM, Findlay JK. Effects of activin and follicle-stimulating hormone(FSH)-suppressing protein/follistatin on FSH receptors and differentiation of cultured rat granulosa cells[J]. Endocrinology,1992,131:1009.
[90]Matzuk MM, Finegold M J, Su J-G J. a-lnhibin is a tumour-suppressor gene with gonadal specificity in mice[J]. Nature,1992,360:313.
[91]McLachlan RI, Robertson DM, Healy DL. Circulating immunoreactive inhibin levels during the normal human menstrual cycle[J]. J Clin Endocrinol Metab,1987,65:954.
[92]Buckler HM. Healy DL, Burger HG. Purified FSH stimulates inhibin production from the human ovary[J]. J Endocrinol,1989,122:279.
[93]Groome NP, lllingworth PG,0'Brien M. Measusrement of dimeric inhibin B throughout the human menstrual cycle[J]. J C/in Endocrinol Metab,1996,81:1401.
[94]Lockwood GM, Muttukrishna S, Ledger WL. Inhibins and activins in human ovulation, conception and pregnancy[J]. Hum Reprod Update,1998,4:284.
[95]Klein NA, lllingworth PJ, Groome NP. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women:a study of serum and follicular fluid leavels of dimeric inhibin A and B in spontaneous menstrual cycles[J]. J Clin Endocrinol Metab,1996,81:2742.
[96]Lockwood GM, Muttukrishna S, Groome NP. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy:a possible mechanism regulating emergence of the dominant follicle[J]. J Clin Endocrinol Metab,1998,83:1730.
[97]Hofmann GE, Danforth DR, Seifer DB. Inhibin-B:the physiologic basis of the clomiphene citrate challenge test for ovarian reserve screening [J]. Fertil Steril,1998,69:474.
[98]Ling N, Ying S, Ueno N. Pituitary FSH is released by a heterodimer of the subunits frum the two forms of inhibin[J]. Nature,1986,321:779.
[99]Braden TI, Conn PM. Activin-A stimulates the synthesis of gonadotropin-releasing hormone receptors[J]. Endocrinology,1992,130: 2101.
[100]Hillier SG, Yong EL, Illingworth PJ. Effect of recombinant inhibin on androgen synthesis in cultured human thecal cells [J]. Mol Cell Endocrinol, 1991,75:R1.
[101]Hillier SG, Yong EL, Illingworth PJ. Effect of recombinant activin on androgen synthesis in cultured human thecal cells[J]. J Clin Endocrinol Metab,1991,72:1206.
[102]Sawetawan C, Carr BR, McGee E. Inhibin and activin differentially regulate androgen production and 17a-hydroxylase expression in human ovarian thecal-like cells[J]. J Endocrinol,1996,148:213.
[103]Kaiser UB, Lee BL, Carroll RS, Unabia G. Follistatin gene expression in the pituitary:localization in gonadotrophs and folliculostellate cells in diestrous rats[J]. Endocrinoloy,1992,130:3048.
[104]Kogawa K, Nakamura T, Sugiono K. Activin-binding protein is present in pituitary[J]. Endocrinoloy,1991,128:1434.
[105]Besecke LM, Guendner M J, Sluss PA. Bauer-Dantoin AC, Weiss J, Pituitary follistatin regulates activin-mediated production of follicle-stimulating hormone during the rat estrous cycle[J]. Endocrinology,1997,138:2841.
[106]Robertson DM. Follistatin/activin-binding protein Trends[J]. Endocrinol Metab,1992,3:65.
[107]Adashi EY. Cytokine-mediated regulation of ovarian function:encounters of a third kind[J]. Endocrinology,1989,124:2043.
[108]马宝璋.中医妇科学[M].第6版.上海:科学技术出版社,1997.
[109]Takamizawa S, Shibahara H, Shibayama T, et al. Detection of antizona pellucida antibodies in the sera from premature ovarian failure patients by a highly specific test[J]. Fertil Steril,2007, Mar, Epub ahead of print.
[110]杨桂艳.卵巢早衰与免疫[J].国外医学妇幼保健分册,1997,8：59-61.
[111]Smith S & Hosid S. Premature ovarian failure associated with autoantibodies ot the zona pellucida[J]. Int J Fertil,1994,39(6):316-319.
[112]ChattoPadhyay D, Sen MR, Chat EN, et al. Antiovarian antibody in Premature ovarian failure[J]. Indian J Med Sci,1999,53(6):254-258.
[113]Holland CM.47, XXX in an adolescent with Premature Ovarian failure and autoimmune disease[J]. J Pediatr Adolesc Gynecol,2001,14(2):77-80.
[114]Ishizuka B, Kudo Y, Amemiya A, et al. Anti-nucluear antibodies in pations with premature ovarian failure[J]. Hum Reprod,1999,14(1):70-75.
[115]Chernyshov V P, Radysh TV, Gura IV, et al. Immune disorders in women with premature ovarian failure in initial period[J]. A m J Reprod lmmunol,2001,46(3):220-225.
[116]杨桂艳,王一理,曹攒孙,等.卵巢早衰患者外周CD4+、Th1/Th2细胞分布研究[J].生殖医学杂志,1998,7(4)：227-230.
[117]王一峰,欧汝强,杨宁,等.卵巢早衰患者血清抗透明带抗体和肿瘤坏死因子-α,β-干扰素及白细胞介素-2的分析[J].生殖医学杂志,2002,11(1)：7-10.
[118]Rusell P. The clinic pathological feature, premature ovarian failure[J]. Verh Dtsch Ges Pathol,1997,81:197.
[119]Zhang P, Shi YH, Wang LC, et al. Sequence variants in exons of the BMP-15 gene in Chinese patients with POF[J]. Acta Obstet Gynecol Scand,2007,86(5): 585-589.
[120]史文静,赵怡漩.卵巢早衰[J].国外医学妇幼保健分册,2002,13(1)：7-9.
[121]倪虹.卵巢早衰[J].国外医学妇产科学分册,2001,28(2)：85-7.
[122]Toner JP, Philput CB, Jones GS, et al. Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age[J]. Fertil Steril,1991,55:784.
[123]Pearlstone AC, Fournet N, Gambone JC, et al. Ovulation induction in women age 40 and older:the importance of basal follicle-stimulating hormone level and chronological age[J]. Fertil Steril,1992,58:674.
[124]Smotrich DB, Widra EA, Gindoff PR, et al. Prognostic value of day 3 estradiol on in vitro fertilization outcome[J]. Fertil Steril, 1995,64:1136.
[125]Buyalos RP, Daneshmand S,Brzechchffa PR. Basal estradiol and follicle-stimulating hormone predict fecundity in women of advanced reproductive age undergoing ovulation induction therapy [J]. Fertil Steril, 1997,68:272.
[126]Hofmann GE, Danforth DR, Seifer DB[J]. Fertil Steril,1998,69(3):474.
[127]Tinknaen HB, Blauerl, LaiPPata P, et al. Correlation between serum inhibinB and other inditions of the ovarian function[J]. Eur J Obstet-Gynecol RePrd Biol,2001,94(1):103-113.
[128]Scott Jr RT, Opsahl MS, Leonardi MR, et al. Illions EH, Navot D. Life table analysis of prenancy rates in a general infertility population relative to ovarian reverse and patient age[J]. Hum Repord,1995,10:1706.
[129]Sinna P, Kuruba N. Premature ovarian failure[J]. J Obstet Gynaecol,2007,27(1):16-19.
[130]Davis SR, Burger HG. The role of androgen therapy[J]. Best Pract Res Clin Endocrinol Metab,2003,17(1):165.
[131]Check JH, Summers D, Nazari A, et al. Successful pregnancy following in vitro fertilization embryo transfer despite imminent ovarian failure[J]. Clin Exp Obset Gynecol,2000,27(2):97-99.
[132]Lydic ML, Liu JH, Rebar RW, et al. Success of donor occyte in in vitro fertilization-embryo transfer in recipients with and without premature ovarian failure[J]. Fertil Steril,1996, Jam:98-102.
[133]Lam lT, Schulz-Lobmery I, Obruca A, et al. Premature ovarian failure: etioiogy and prospects [J]. Gynecol Endocrinol,2000,14(7):1777.
[134]Kim SS, Battaglia DE, Soules MR. The future of human ovarian cryopreservation and transplantion:fertility and beyond[J]. FertilSteril,2001,76(5):1049.
[135]赵建春,徐萍,宋亚光.中西医结合治疗卵巢早衰40例观察[J].四川中医,2004,22(7)：69-70.
[136]邢红梅,韩连玉,陈琛.中医综合疗法治疗卵巢早衰28例疗效观察[J].新中医,2005,37(11)：28-29.
[137]钟雪梅,代嘉莉,李宗恒.补肾养经汤合人工周期法治疗卵巢早衰38例临床观察[J].江苏中医药,2005,26(8)：21-22.
[138]黄逸玲,楼莲娟,蒋珺瑛.补肾养阴方治疗卵巢早衰临床新探[J].实用中医药杂志,2006,22(5)：265-267.
[139]赵建春,徐萍,宋亚光.巢衰复元汤治疗卵巢早衰38例临床观察[J].北京中医药大学学报,2006,13(6)：23-25.
[140]梁雪雯,苏建芬,王迪华,等.逍遥助卵煎治疗卵巢早衰30例[J].上海中医药杂志,2006,40(2)：31-32.
[141]秦佳佳.中西医结合疗法治疗卵巢早衰72例临床观察[J].四川中医,2006,24(8)：86-87.
[142]施丽洁.归肾汤加味治疗卵巢早衰30例[J].中医杂志,2007,48(2)：152-153.
[143]蒋贵林,王转丽,刘晓燕,等.归肾丸合热敏灸治疗卵巢早衰32例[J].江西中医药,2007,38(300)：45-46.
[144]邢红梅,祝佩芹,李建茹.健脾补肾中药配合穴位艾灸治疗卵巢早衰的临床研究[J].新中医,2007,39(4)：26-27.
[145]王金莲,刘宇新.抗衰复巢汤合人工周期疗法治疗卵巢早衰30例临床观察[J].新中医,2007,39(2)：36-37.
[146]王迪华,梁雪雯,周红.逍遥助卵煎对卵巢早衰患者血清性激素水平的影响[J].中国妇幼保健,2007,22(33)：4688.
[147]北京知医堂妇科疾病研究中心.中西医综合治疗卵巢早衰、乳腺增生、盆腔炎的临床研究[J].中国医药指南,2007,9(17)：142-143.
[148]孙永忠,金华,程泾.滋肾益冲抗衰汤治疗卵巢早衰的临床研究[J].浙江中西医结合杂志,2007,17(5)：278-280.
[149]周焰焰.中西医结合治疗卵巢早衰30例疗效观察[J].中国中西医结合杂志,2008，28(1)：84-85.
[150]卢晓男,徐向荣,林丽君.补肾二仙汤治疗卵巢早衰的临床观察[J].中国中西医结合杂志,2008,28(7)：594-596.
[151]曹丽琴,张蔷蓉,叶天真,等.补肾抗衰汤联合人工周期疗法治疗卵巢早衰临床观察[J].中草药,2008,39(7)：1067-1068.
[152]易旺云,顾秀兰,刘超强,等.激素替代联合中药治疗卵巢早衰临床疗效观察[J].中国妇幼保健,2008,23(32)：4563-4565.
[153]朱也君.加味左归丸治疗卵巢早衰继发性闭经30例[J].辽宁中医杂志,2008,35(3)：407-408.
[154]韩连玉,叶亚智,祝佩芹,等.抗卵衰冲剂治疗卵巢早衰36例临床研究[J].辽宁中医杂志,2008,35(3)：404-405.
[155]许学风.理冲汤联合激素替代治疗卵巢早衰32例临床分析[J].中国妇幼保健,2008,23(13)：1883-1884.
[156]张勇.清热活血法联合西药治疗自身免疫性卵巢早衰对比研究[J].济宁医学院学报,2008,31(2)：155-156.
[157]龙田.清热活血法治疗自身免疫性卵巢早衰临床研究[J].中国实用医药,2008,3(29)：26-28.
[158]李颖,朱明辉,马仲丽.益肾养元丹治疗卵巢早衰90例临床观察[J].中国现代药物应用,2008,2(7)：31-32.
[159]祁慧娇,胡慧娟,谢一红.中西医结合治疗卵巢早衰26例临床观察[J].山东中医杂志,2008,27(6)：398-399.
[160]黄玉梅,罗爱鄂.中西医结合治疗卵巢早衰45例[J].江西中医药,2008,39(302)：35.
[161]韩连玉,叶亚智,祝佩芹,等.中西医结合治疗卵巢早衰58例疗效观察[J].中国全科医学,2008,11(2B)：343-344.
[162]高学娟,毕华.中药周期疗法配合HRT治疗特发性卵巢早衰63例[J].山东中医杂志,2008,27(12)：814-815.
[163]邢红梅,王蕊,杨华.自拟补肾健脾方配合艾灸治疗卵巢早衰的临床研究[J].疑难病杂志,2008,7(2)：101-102.
[164]杜嫦燕,柴洪佳,邹志洁.补肾养肝汤治疗卵巢早衰40例临床观察[J].新中医,2009,41(10)：49-50.
[165]张蕾.补肾养肝汤治疗卵巢早衰45例[J].四川中医,2009,27(11)：89-90.
[166]刘娜,王永宏,熊利.益肾抗衰汤配合克龄蒙治疗肾虚型卵巢早衰的临床观察[J].湖南中医药大学学报,2009,29(3)：49-51.
[167]赵少华,赵秀管.二仙汤加味治疗卵巢早衰的临床观察[J].河北中医,2009,31(4)：518-519.
[168]曹怀宁.二至地黄汤对卵巢早衰患者激素水平及抗卵巢抗体影响的临床研究[J].新中医,2009,41(9)：53-54.
[169]王蕊,邢红梅,何芳.健脾补肾方联合艾灸对卵巢早衰患者生存质量及阴道脱落细胞成熟度的影响[J].中医杂志,2009,50(7)：606-608.
[170]芦莉.中西医结合治疗高原地区卵巢早衰67例疗效观察[J].高原医学杂志,2009,19(3)：57.
[171]李小林,吴献群.中西医结合治疗卵巢早衰36例[J].现代中医药,2009,29(1)：24-25.
[172]李孔益,彭清慧.中西医结合治疗卵巢早衰36例观察[J].实用中医药杂志,2009,25(11)：749-750.
[173]马晓玲.滋卵汤结合人工周期治疗高海拔地区卵巢早衰75例[J].陕西中医,2009,30(11)：1455-1456.
[174]王利平.补肾祛瘀法治疗卵巢功能早衰48例[J].陕西中医,2010,31(3)：264-265.
[175]宁艳,林琼霞,单志群,等.补肾益冲丸治疗肾虚型卵巢早衰患者的临床观察[J].河北医学,2010,16(2)：129-132.
[176]高翠霞.补肾活血、疏肝健脾法治疗卵巢早衰38例[J].河南中医,2010,30(11)：1098-1099.
[177]王慧民,朱雪梨,胡丽莎.补肾活血法对卵巢早衰免疫因素干预的临床观察[J].江西医药,2010,45(12)：1172-1174.
[178]叶亚智,韩连玉,张涛,等.抗卵衰冲剂治疗卵巢早衰患者抗卵巢抗体阳性45例疗效观察[J].河北中医,2010,32(4)：515-516.
[179]赵仁霞.二仙汤加味治疗卵巢早衰临床观察[J].中国中医药信息杂志,2010,17(1)：62-63.
[180]梁卓,王昕,刘宇新.抗衰复巢汤治疗卵巢早衰临床观察[J].辽宁中医杂志,2010,37(10)：1978-1979.
[181]丁青,吴紫玉,聂玲.护卵汤治疗心肾不交型卵巢早衰的临床观察[J].湖南中医药大学学报,2010,30(9)：184-186.
[182]黎志远,杨贤海,李天春,等.疏肝化瘀益气补肾法联合热敏灸治疗卵巢早衰62例临床观察[J].四川中医,2010,28(12)：86-88.
[183]徐华.坤泰胶囊联合雌孕激素序贯疗法治疗卵巢早衰临床分析[J].中国初级卫生保健,2010,24(9)：60-70.
[184]谷雨,谷志国.四二五合方治疗卵巢早衰40例临床观察[J].长春中医药大学学报,2010,26(3)：409.
[185]曹毅君,谭洁,戴洁.中西医结合治疗卵巢功能早衰疗效分析[J].中华全科医学,2010,8(11)：1411-1412.
[186]伍朝霞,李春娣,张立恒.益肾活血汤口服配合按摩治疗卵巢早衰59例[J].辽宁中医杂志,2010,37(8)：1533-1534.
[187]刘丽清,郭树榜,刘雁,等.中西医结合治疗卵巢早衰30例临床观察[J].山西中医,2010,26(7)：39-40.
[188]韦艳萍,赵苏萍,李远珺,等.左归丸联合艾灸治疗卵巢早衰的临床研究[J].右江医学,2010,38(2)：168-170.
[189]朱黎莉.中西医结合治疗卵巢早衰48例临床观察[J].临床医药实践,2009,8(5)：387-388.
[190]谢亚莉,王忠英,杨帆.中药复方治疗卵巢早衰39例临床观察[J].辽宁中医杂志,2010,37(12)：2359-2360.
[191]张华军,李雪莲.中医药综合疗法治疗卵巢早衰36例临床研究[J].中国中医药现代远程教育,2010,8(17)：48-49.
[192]左雨秀治.当归药理实验研究[J].医学生物学,1982,104(3)：159.
[193]周金黄,王药默.中药药理学[M].上海：上海科学出版社,1986：267.
[194]高向东.五种抗衰老中药对小鼠T-淋巴细胞增殖与IL-2产生的影响[J].中国 药科大学报,1990,21(1)：43.
[195]秦达念.菟丝子黄酮对实验动物及人绒毛组织生殖功能的影响[J].中药新药与临床药理,2000,11(6)：349-351.
[196]金治萃,贾彦彬,王晓立.山植、枸杞煎剂对红细胞免疫功能的影响[J].包头医学院学报,1997,13(1)：8-9.
[197]刘艳红,赵胜利,石瑞如.黄芪、枸杞对衰老大鼠血浆LPO、SOD及某些激素的影响[J].中药药理与临床,1996,12(2)：20-22.
[198]李炳如,佘运初.补肾对下丘脑-垂体-性腺轴功能的影响[J].中医杂志,1984,25(7)：63-64.
[199]卞以洁.仙灵脾对M受体-cGMP系统的调节作用[J].中国中药与临床,1988,(3)：29.
[200]王永祥,陈敏珠,徐淑云.白芍总甙的镇痛作用[J].中国药理学与毒理学杂志,1988,2(1)：6.
[201]明·万全.万氏女科[M].北京：中国中医药出版社,1998：363.
[202]宋·陈素庵.陈素庵妇科补解[M].上海：上海科学技术出版社,1983：170.
[2]杨业洲,韩字研.卵巢早衰的防治原则[J].实用妇产科杂志,2003,4(19)：201-203.
[3]Hofmann GE. Danforth DR. Seifer DB[J]. Fertil Steril.1998,69(3):474.
[4]Zheng W, Magid MS, Kramer EE. Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube[J]. Am J Pathol,1996,148:47.
[5]王菊素.田淑霄教授对卵巢早衰与肾虚血瘀相关性的见解及治疗经验[J].陕西中医,2003,24(11)：10-15.
[6]李艳石,王禹.王秀云教授治疗卵巢早衰经验拾萃[J].中医药学刊,2005,23(1)：31.
[7]邢翠玲,杨玉荣.中西医结合治疗卵巢早衰310例[J].国医论坛,1995,10(3)：20.
[8]许昕.补肾养血调经法治疗有卵泡型卵巢早衰[J].北京中医,2001,(4)：21.
[9]沈慰,俞超芹.从肾论治卵巢早衰[J].中西医结合学报,2006,11(4)：653.
[10]梁静雅.连方教授治疗卵巢早衰性不孕经验[J].四川中医,2010,28(11)：14-15.
[11]马景,何嘉琳.何嘉琳治疗卵巢早衰的临床经验[J].浙江中医杂志,2009,44(4)：260-261.
[12]黄健萍.卵巢早衰的中医治疗述要[J].辽宁中医学院学报,2004,6(2)：126.
[13]蔡立荣.补肾活血方对小鼠实验性卵巢早衰防治作用的研究[J].中国中西医结合杂志,2001,21(2)：126.
[14]钱海墨,范晓艳,陈颖异.陈颖异治疗卵巢早衰经验[J].中医杂志,2009,50(5)：402-403.
[15]施艳秋.乌鳖口服液治疗卵巢功能早衰的临床与实验研究总结[J].中华实用中西医杂志,2004,17(4)：425.
[16]史云,蔡平平,邓高丕.张玉珍教授治疗卵巢早衰经验介绍[J].新中医,2006,38(9)：15.
[17]庞震苗,熊学军.张玉珍治疗卵巢早衰验案举隅[J].辽宁中医杂志,2006,33(10)：1348.
[18]王芳,张丽君.卵巢早衰的病因病机及辨证治疗概况[J].江西中医药,2007,38(10)：70.
[19]兰英,柴巍.柴瑞霭治疗卵巢早衰验案举隅[J].山西中医,2001,17(4)：5.
[20]夏天.卵巢早衰的中西医结合研究进展[J].辽宁中医杂志,2004,33(8)：707.
[21]张朝辉,张亚辉.阳和汤治疗卵巢早衰症治验[J].北京中医,2001,17(4)：16.
[22]陈秀芳.辨证治疗卵巢早衰22例[J].四川中医,2000,18(1)：35.
[23]朱玲,罗颂平.卵巢早衰的病因病机及其证治[J].中医药学刊,2003,21(1)：143.
[24]徐萍.巢衰汤治疗卵巢早衰31例报告[J].甘肃中医,2003,16(6)：31.
[25]胡向丹,李丽芸.李丽芸教授治疗卵巢早衰的经验撷要[J].新中医,2010,42(7)：127-128.
[26]滕秀香.122例卵巢早衰患者中医证候分析及致病因素调查[J].中国中医药信息杂志,2008,15(4)：18-20.
[27]姚石安.卵巢早衰中医证治需注意哪些方面[J].中医杂志,1998,39(5)：313.
[28]杨兰英.六味地黄丸治疗卵巢早衰的实验研究[J].山西中医学院学报,2002,3(1)：21-23.
[29]张立.卵巢早衰36例分析及其治疗[J].中医药学刊,2003,21(4)：619.
[30]温鸿雁,范智斌.卵巢早衰的中西医研究近况[J].中医药研究,2001,17(6)：49.
[31]罗绍松.一贯煎加减治疗卵巢功能早衰38例疗效观察[J].贵阳中医学院学报,1998,20(4),19-20.
[32]周华,赵春梅.中西医治疗卵巢早衰临床研究述略[J].中医药学刊,2004,22(5)：903.
[33]杨利侠.卵巢早衰的中医药证治思路与方法[J].四川中医,2005,23(8)：11.
[34]李云君.姜惠中治疗卵巢早衰的经验[J].湖北中医杂志,2006,2(6)：28-29.
[35]李晨辉.中医治疗卵巢早衰50例[J].现代中西医结合杂志,2007,16(34)：5139-5140.
[36]胡道敏,吴克明.加减苁蓉菟丝子丸治疗卵巢早衰疗效分析[J].甘肃中医,2010,23(9)：43-44.
[37]周佩云,黄裕晓,吴伍香.蔡连香教授采用中药内服外用治疗卵巢早衰经验[J].中华中医药杂志,2010,25(10)：1613-1615.
[38]佟庆.柴松岩诊治卵巢早衰经验[J].北京中医药,2009,28(3)：196-197.
[39]伍娟娟.尤昭玲治卵巢早衰经验[J].江西中医药,2009,40(5)：27.
[40]杜晓萍,梅乾茵.梅乾茵治疗卵巢早衰经验[J].江西中医药,2008,39(10)：16-17.
[41]原迪.刘宇新教授益气生精法治疗卵巢早衰经验[J].现代中西医结合杂志,2009,18(18)：2188-2189.
[42]龙莉,韩延华.韩延华教授治疗卵巢早衰经验介绍[J].新中医,2008,40(8)：3.
[43]张蕾,曲秀芬.曲秀芬教授治疗卵巢早衰经验拾萃[J].杏林中医药,2009,29(7)：565-566.
[44]任洁宁,杨鉴冰.杨鉴冰教授治疗卵巢早衰用药经验介绍[J].现代中医药,2009,29(3)：1-2.
[45]杨鉴冰,侯秀环.归肾丸加减治疗卵巢早衰的临床观察[J].陕西中医学院学报,1995,18(37),24-25.
[46]李宗恒,钟雪梅,代加莉.雌激素顺序法与补经汤治疗卵巢早衰的比较观察[J].中国中医药科技,2002,9(3)：17.
[47]史云,张玉珍.补肾健脾调肝活血法治疗卵巢功能早衰临床观察[J].中医药学刊,2006,24(6)：1174-1176.
[48]刘枫林,许妙玲.黄果补血汤治疗卵巢功能早衰36例[J].云南中医药杂志,1997,18(1)：27-28.
[49]王璇.仙乐雄胶囊治疗卵巢早衰闭经47例临床观察[J].基层中药杂志,1999,13(4)：55.
[50]陈国姿,徐红.中药人工周期疗法治疗卵巢功能早衰继发性闭经32例[J].广东医学,1999,20(10)：782.
[51]高露露,谢亚莉.谢亚莉教授治疗卵巢早衰之经验[J].辽宁中医药大学学报,2009,11：100-102.
[52]庆璐,武淑慧.崔晓萍教授循期阴阳序贯治疗卵巢早衰经验总结[J].陕西中医学院学报,2010,33(5)：22-23.
[53]徐洁,蔡昱,谢群.卵巢早衰的中西医结合治疗与预防[J].中国当代医学,2005,4(7)：83.
[54]刑翠玲,杨玉荣.中西医结合治疗卵巢早衰310例[J].国医论坛,1995,10(3)：20.
[55]秦佳佳.中西医结合疗法治疗卵巢早衰72例临床观察[J].四川中医,2006,24(8)：86.
[56]衣忠玲.卵巢早衰治疗体会[J].实用中医药杂志,2000,16(9)：38.
[57]和平,张艳婷.中西医结合治疗卵巢早衰早期的临床探讨[J].云南中医中药杂志,2004,25(2)：3-4.
[58]许昕,腾秀香,佟庆.补肾养血调经法治疗有卵泡型卵巢早衰[J].北京中医,2001,(4)：21-22.
[59]Rabinovici J, Jarfe RB. Development and regulation of growth and differentiated funtion of human and subhuman primate fetal gonads[J]. Endocr Rev,1990,11:532.
[60]Baker TG. A quantitative and cytological study of germ cells in human ovaries[J]. Proc Roy Soc Lond,1963,158:417.
[61]Condos B, Bhiraleus P, Hobel C. Ultrastructural observations on germ cells in human fetal ovaries[J]. Am J Obstet Gynecol,1986,155:189.
[62]Ammini AC, Pandey J, Vijyaraghavan M, et al. Human female phenotypic development:role of fetal ovaries[J]. J Clin Endocrinol Metab,1994,79:604.
[63]Burger HG, Famada Y, Bangah ML. Serum gonadotropin, sex steroid, and immunoreactive inhibin levels in the first two years of life[J]. J Clin Endocrinol Metab,1991,72:682.
[64]Richardson S J, Senikas V, Nelson JF. Follicular depletion during the menopausal transition—evidence for accelerated loss and ultimate exhaustion[J]. J Clin Endocrinol Metab,1987,65:1231.
[65]Tilly JL, Kowalski KI, Schomberg DW. Apoptosis in atretic ovarian follicles is associated with selected decreases in messenger ribonucleic acid transcripts for gonadotropin receptors and cytochrome P450 aromatase[J]. Endocrinology,1992,131:1670.
[66]Dees WL, Hiney JK Schultea TD. The primate ovary contains a population of catecholaminergic neuron-like cells expressing nerve growth factor receptors[J]. Endocrinology,1995,136:5760.
[67]Peters H, Byskov AG, Himelstein. Follicular growth:the basic event in the mouse and human ovary[J]. J Reprod Fertil,1975,45:559.
[68]Gougeon A, Echochard R, Thalabard JC. Age-related changes of the population of human ovarian follicles:increase in the disappearance rate of non-growing and early-growing follicles in aging women[J]. Biol Reprod,1994,50:653.
[69]Mais v, Kazer RR, Cetel NS. The dependency of folliculogenesis and corpus luteum-function on pulsatile gonadotropin secretion in cycling women using a gonadotropin-releasing hormone antagonist as a probe[J]. J Clin Endocrinol Metab,1986,62:1250.
[70]Oktay K, Newton H, Mullan J. Development of human primordial follicles to antral stages in SCID/hpg mice stimulated with follicle stimulating hormone[J]. Hum Reprod,1998,13:1133.
[71]Schipper I, Hop WCJ, Fauser BCJM. The follicle-stimulating hormone threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development[J]. J Clin Endocrinol Metab,1998,83:1292.
[72]Oktay K, Briggs DA, Gosden RG. Ontogeny of follicle-stimulating hormone receptor gene expression in isolated human ovarian follicles[J]. J Clin Endocrinol Metab,1997,82:3748.
[73]Yong EL, Baird DT, Hillier SG. Mediation of gonadotropinstimulated growth and differentiation of human granulosa cells by adenosine-3',5-monophosphate:one molecule, two messages[J]. Clin Endocrinol,1992,37:51.
[74]LaPolt PS, Tilly JL, Aihara T. Gonadotropin-induced up and down regulation of ovarian follicle-stimulating hormone(FSH)receptor gene expression in immature rats:effects of pregnant mare's serum gonadotropin, human chorionic gonadotropin, and recombinant FSH[J]. Endocriw nology,1992,130:1289.
[75]Tilly JL, LaPolt PS, Hsueh AJ. Hormonal regulation of follicle-stimulating hormone receptor messenger ribonucleic acid levels in cultured rat granulosa cells[J]. Endocrinology,1992,130:1296.
[76]Hild-Petito S, West NB, Brenner RM. Localization of androgen receptor in the follicle and corpus luteum of the primate ovary during the menstrual cycle[J]. Biol Reprod,1991,44:561.
[77]Erickson GF, Magoffin DA, Dyer CA. The ovarian androgen producing cells: a review of structure/function relationships [J]. Endocr Rev,1985,6:371.
[78]Andersen CY, Characteristics of human follicular fluid associated with successful conception after in vitro fertilization[J]. J Clin Endocrinol Metab,1993,77:1227.
[79]Erickson GF, An analysis of follicle development and ovum maturation[J]. Seminars Reprod Endocrinol,1986,4:233.
[80]McNatty KP, Markris A, DeGraziak C. Steroidogenesis by recombined follicular cells from the human ovary in vitro[J]. J Clin Endocrinol Metab,1980,51:1286.
[81]McNatty KP, Smith DM, Makris A. The intraovarian sites of androgen and estrogen formation in women with normal and hyperandrogenic ovaries as judged by in vitro experiments [J]. J Clin Endocrinol Metab,1980,50:755.
[82]Hillier SG. Paracrine control of follicular estrogen synthesis[J]. Seminars Reprod Endocrinol,1991,9:332.
[83]Kobayashi M, Nakano R, Ooshima A. Immunohistochemical localization of pituitary gonadotropins and gonadal steroids confirms the two cells two gonadotropins hypothesis of steroidogenesis in the human ovary[J]. J Endocrinol,1990,126:483.
[84]Yamoto M, Shima'K, Nakano R. Gonadotropin receptors in human ovarian foil icles and corpora lutea throughout the menstrual cycle[J]. Hot Res,1992,37(Suppl 1):5.
[85]Magoffin DA. Regulation of differentiated functions in ovarian theca cells[J]. Seminars Reprod Endocrinol,1991,9:321.
[86]Sasano H, Okamoto M, Mason JI. Immunolocalization of aromatase 17ct-hydroxylase and side-chain-cleavage cyto-chromes P-450 in the human ovary[J]. J Reprod Fertil,1989,85:163.
[87]Rivier C, Rivier j,Vale W. Inhibin-mediated feedback control of follicle-stimulating hormone secretion in the female rat[J]. Science,1986,234:205.
[88]Bicsak TA, Tucker EM, Cappel S. Hormonal regulation of granulosa cell inhibin biosynthesis[J]. Endocrinology,1986,119:271.
[89]Xiao S, Robertson DM, Findlay JK. Effects of activin and follicle-stimulating hormone(FSH)-suppressing protein/follistatin on FSH receptors and differentiation of cultured rat granulosa cells[J]. Endocrinology,1992,131:1009.
[90]Matzuk MM, Finegold M J, Su J-G J. a-lnhibin is a tumour-suppressor gene with gonadal specificity in mice[J]. Nature,1992,360:313.
[91]McLachlan RI, Robertson DM, Healy DL. Circulating immunoreactive inhibin levels during the normal human menstrual cycle[J]. J Clin Endocrinol Metab,1987,65:954.
[92]Buckler HM. Healy DL, Burger HG. Purified FSH stimulates inhibin production from the human ovary[J]. J Endocrinol,1989,122:279.
[93]Groome NP, lllingworth PG,0'Brien M. Measusrement of dimeric inhibin B throughout the human menstrual cycle[J]. J C/in Endocrinol Metab,1996,81:1401.
[94]Lockwood GM, Muttukrishna S, Ledger WL. Inhibins and activins in human ovulation, conception and pregnancy[J]. Hum Reprod Update,1998,4:284.
[95]Klein NA, lllingworth PJ, Groome NP. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women:a study of serum and follicular fluid leavels of dimeric inhibin A and B in spontaneous menstrual cycles[J]. J Clin Endocrinol Metab,1996,81:2742.
[96]Lockwood GM, Muttukrishna S, Groome NP. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy:a possible mechanism regulating emergence of the dominant follicle[J]. J Clin Endocrinol Metab,1998,83:1730.
[97]Hofmann GE, Danforth DR, Seifer DB. Inhibin-B:the physiologic basis of the clomiphene citrate challenge test for ovarian reserve screening [J]. Fertil Steril,1998,69:474.
[98]Ling N, Ying S, Ueno N. Pituitary FSH is released by a heterodimer of the subunits frum the two forms of inhibin[J]. Nature,1986,321:779.
[99]Braden TI, Conn PM. Activin-A stimulates the synthesis of gonadotropin-releasing hormone receptors[J]. Endocrinology,1992,130: 2101.
[100]Hillier SG, Yong EL, Illingworth PJ. Effect of recombinant inhibin on androgen synthesis in cultured human thecal cells [J]. Mol Cell Endocrinol, 1991,75:R1.
[101]Hillier SG, Yong EL, Illingworth PJ. Effect of recombinant activin on androgen synthesis in cultured human thecal cells[J]. J Clin Endocrinol Metab,1991,72:1206.
[102]Sawetawan C, Carr BR, McGee E. Inhibin and activin differentially regulate androgen production and 17a-hydroxylase expression in human ovarian thecal-like cells[J]. J Endocrinol,1996,148:213.
[103]Kaiser UB, Lee BL, Carroll RS, Unabia G. Follistatin gene expression in the pituitary:localization in gonadotrophs and folliculostellate cells in diestrous rats[J]. Endocrinoloy,1992,130:3048.
[104]Kogawa K, Nakamura T, Sugiono K. Activin-binding protein is present in pituitary[J]. Endocrinoloy,1991,128:1434.
[105]Besecke LM, Guendner M J, Sluss PA. Bauer-Dantoin AC, Weiss J, Pituitary follistatin regulates activin-mediated production of follicle-stimulating hormone during the rat estrous cycle[J]. Endocrinology,1997,138:2841.
[106]Robertson DM. Follistatin/activin-binding protein Trends[J]. Endocrinol Metab,1992,3:65.
[107]Adashi EY. Cytokine-mediated regulation of ovarian function:encounters of a third kind[J]. Endocrinology,1989,124:2043.
[108]马宝璋.中医妇科学[M].第6版.上海:科学技术出版社,1997.
[109]Takamizawa S, Shibahara H, Shibayama T, et al. Detection of antizona pellucida antibodies in the sera from premature ovarian failure patients by a highly specific test[J]. Fertil Steril,2007, Mar, Epub ahead of print.
[110]杨桂艳.卵巢早衰与免疫[J].国外医学妇幼保健分册,1997,8：59-61.
[111]Smith S & Hosid S. Premature ovarian failure associated with autoantibodies ot the zona pellucida[J]. Int J Fertil,1994,39(6):316-319.
[112]ChattoPadhyay D, Sen MR, Chat EN, et al. Antiovarian antibody in Premature ovarian failure[J]. Indian J Med Sci,1999,53(6):254-258.
[113]Holland CM.47, XXX in an adolescent with Premature Ovarian failure and autoimmune disease[J]. J Pediatr Adolesc Gynecol,2001,14(2):77-80.
[114]Ishizuka B, Kudo Y, Amemiya A, et al. Anti-nucluear antibodies in pations with premature ovarian failure[J]. Hum Reprod,1999,14(1):70-75.
[115]Chernyshov V P, Radysh TV, Gura IV, et al. Immune disorders in women with premature ovarian failure in initial period[J]. A m J Reprod lmmunol,2001,46(3):220-225.
[116]杨桂艳,王一理,曹攒孙,等.卵巢早衰患者外周CD4+、Th1/Th2细胞分布研究[J].生殖医学杂志,1998,7(4)：227-230.
[117]王一峰,欧汝强,杨宁,等.卵巢早衰患者血清抗透明带抗体和肿瘤坏死因子-α,β-干扰素及白细胞介素-2的分析[J].生殖医学杂志,2002,11(1)：7-10.
[118]Rusell P. The clinic pathological feature, premature ovarian failure[J]. Verh Dtsch Ges Pathol,1997,81:197.
[119]Zhang P, Shi YH, Wang LC, et al. Sequence variants in exons of the BMP-15 gene in Chinese patients with POF[J]. Acta Obstet Gynecol Scand,2007,86(5): 585-589.
[120]史文静,赵怡漩.卵巢早衰[J].国外医学妇幼保健分册,2002,13(1)：7-9.
[121]倪虹.卵巢早衰[J].国外医学妇产科学分册,2001,28(2)：85-7.
[122]Toner JP, Philput CB, Jones GS, et al. Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age[J]. Fertil Steril,1991,55:784.
[123]Pearlstone AC, Fournet N, Gambone JC, et al. Ovulation induction in women age 40 and older:the importance of basal follicle-stimulating hormone level and chronological age[J]. Fertil Steril,1992,58:674.
[124]Smotrich DB, Widra EA, Gindoff PR, et al. Prognostic value of day 3 estradiol on in vitro fertilization outcome[J]. Fertil Steril, 1995,64:1136.
[125]Buyalos RP, Daneshmand S,Brzechchffa PR. Basal estradiol and follicle-stimulating hormone predict fecundity in women of advanced reproductive age undergoing ovulation induction therapy [J]. Fertil Steril, 1997,68:272.
[126]Hofmann GE, Danforth DR, Seifer DB[J]. Fertil Steril,1998,69(3):474.
[127]Tinknaen HB, Blauerl, LaiPPata P, et al. Correlation between serum inhibinB and other inditions of the ovarian function[J]. Eur J Obstet-Gynecol RePrd Biol,2001,94(1):103-113.
[128]Scott Jr RT, Opsahl MS, Leonardi MR, et al. Illions EH, Navot D. Life table analysis of prenancy rates in a general infertility population relative to ovarian reverse and patient age[J]. Hum Repord,1995,10:1706.
[129]Sinna P, Kuruba N. Premature ovarian failure[J]. J Obstet Gynaecol,2007,27(1):16-19.
[130]Davis SR, Burger HG. The role of androgen therapy[J]. Best Pract Res Clin Endocrinol Metab,2003,17(1):165.
[131]Check JH, Summers D, Nazari A, et al. Successful pregnancy following in vitro fertilization embryo transfer despite imminent ovarian failure[J]. Clin Exp Obset Gynecol,2000,27(2):97-99.
[132]Lydic ML, Liu JH, Rebar RW, et al. Success of donor occyte in in vitro fertilization-embryo transfer in recipients with and without premature ovarian failure[J]. Fertil Steril,1996, Jam:98-102.
[133]Lam lT, Schulz-Lobmery I, Obruca A, et al. Premature ovarian failure: etioiogy and prospects [J]. Gynecol Endocrinol,2000,14(7):1777.
[134]Kim SS, Battaglia DE, Soules MR. The future of human ovarian cryopreservation and transplantion:fertility and beyond[J]. FertilSteril,2001,76(5):1049.
[135]赵建春,徐萍,宋亚光.中西医结合治疗卵巢早衰40例观察[J].四川中医,2004,22(7)：69-70.
[136]邢红梅,韩连玉,陈琛.中医综合疗法治疗卵巢早衰28例疗效观察[J].新中医,2005,37(11)：28-29.
[137]钟雪梅,代嘉莉,李宗恒.补肾养经汤合人工周期法治疗卵巢早衰38例临床观察[J].江苏中医药,2005,26(8)：21-22.
[138]黄逸玲,楼莲娟,蒋珺瑛.补肾养阴方治疗卵巢早衰临床新探[J].实用中医药杂志,2006,22(5)：265-267.
[139]赵建春,徐萍,宋亚光.巢衰复元汤治疗卵巢早衰38例临床观察[J].北京中医药大学学报,2006,13(6)：23-25.
[140]梁雪雯,苏建芬,王迪华,等.逍遥助卵煎治疗卵巢早衰30例[J].上海中医药杂志,2006,40(2)：31-32.
[141]秦佳佳.中西医结合疗法治疗卵巢早衰72例临床观察[J].四川中医,2006,24(8)：86-87.
[142]施丽洁.归肾汤加味治疗卵巢早衰30例[J].中医杂志,2007,48(2)：152-153.
[143]蒋贵林,王转丽,刘晓燕,等.归肾丸合热敏灸治疗卵巢早衰32例[J].江西中医药,2007,38(300)：45-46.
[144]邢红梅,祝佩芹,李建茹.健脾补肾中药配合穴位艾灸治疗卵巢早衰的临床研究[J].新中医,2007,39(4)：26-27.
[145]王金莲,刘宇新.抗衰复巢汤合人工周期疗法治疗卵巢早衰30例临床观察[J].新中医,2007,39(2)：36-37.
[146]王迪华,梁雪雯,周红.逍遥助卵煎对卵巢早衰患者血清性激素水平的影响[J].中国妇幼保健,2007,22(33)：4688.
[147]北京知医堂妇科疾病研究中心.中西医综合治疗卵巢早衰、乳腺增生、盆腔炎的临床研究[J].中国医药指南,2007,9(17)：142-143.
[148]孙永忠,金华,程泾.滋肾益冲抗衰汤治疗卵巢早衰的临床研究[J].浙江中西医结合杂志,2007,17(5)：278-280.
[149]周焰焰.中西医结合治疗卵巢早衰30例疗效观察[J].中国中西医结合杂志,2008，28(1)：84-85.
[150]卢晓男,徐向荣,林丽君.补肾二仙汤治疗卵巢早衰的临床观察[J].中国中西医结合杂志,2008,28(7)：594-596.
[151]曹丽琴,张蔷蓉,叶天真,等.补肾抗衰汤联合人工周期疗法治疗卵巢早衰临床观察[J].中草药,2008,39(7)：1067-1068.
[152]易旺云,顾秀兰,刘超强,等.激素替代联合中药治疗卵巢早衰临床疗效观察[J].中国妇幼保健,2008,23(32)：4563-4565.
[153]朱也君.加味左归丸治疗卵巢早衰继发性闭经30例[J].辽宁中医杂志,2008,35(3)：407-408.
[154]韩连玉,叶亚智,祝佩芹,等.抗卵衰冲剂治疗卵巢早衰36例临床研究[J].辽宁中医杂志,2008,35(3)：404-405.
[155]许学风.理冲汤联合激素替代治疗卵巢早衰32例临床分析[J].中国妇幼保健,2008,23(13)：1883-1884.
[156]张勇.清热活血法联合西药治疗自身免疫性卵巢早衰对比研究[J].济宁医学院学报,2008,31(2)：155-156.
[157]龙田.清热活血法治疗自身免疫性卵巢早衰临床研究[J].中国实用医药,2008,3(29)：26-28.
[158]李颖,朱明辉,马仲丽.益肾养元丹治疗卵巢早衰90例临床观察[J].中国现代药物应用,2008,2(7)：31-32.
[159]祁慧娇,胡慧娟,谢一红.中西医结合治疗卵巢早衰26例临床观察[J].山东中医杂志,2008,27(6)：398-399.
[160]黄玉梅,罗爱鄂.中西医结合治疗卵巢早衰45例[J].江西中医药,2008,39(302)：35.
[161]韩连玉,叶亚智,祝佩芹,等.中西医结合治疗卵巢早衰58例疗效观察[J].中国全科医学,2008,11(2B)：343-344.
[162]高学娟,毕华.中药周期疗法配合HRT治疗特发性卵巢早衰63例[J].山东中医杂志,2008,27(12)：814-815.
[163]邢红梅,王蕊,杨华.自拟补肾健脾方配合艾灸治疗卵巢早衰的临床研究[J].疑难病杂志,2008,7(2)：101-102.
[164]杜嫦燕,柴洪佳,邹志洁.补肾养肝汤治疗卵巢早衰40例临床观察[J].新中医,2009,41(10)：49-50.
[165]张蕾.补肾养肝汤治疗卵巢早衰45例[J].四川中医,2009,27(11)：89-90.
[166]刘娜,王永宏,熊利.益肾抗衰汤配合克龄蒙治疗肾虚型卵巢早衰的临床观察[J].湖南中医药大学学报,2009,29(3)：49-51.
[167]赵少华,赵秀管.二仙汤加味治疗卵巢早衰的临床观察[J].河北中医,2009,31(4)：518-519.
[168]曹怀宁.二至地黄汤对卵巢早衰患者激素水平及抗卵巢抗体影响的临床研究[J].新中医,2009,41(9)：53-54.
[169]王蕊,邢红梅,何芳.健脾补肾方联合艾灸对卵巢早衰患者生存质量及阴道脱落细胞成熟度的影响[J].中医杂志,2009,50(7)：606-608.
[170]芦莉.中西医结合治疗高原地区卵巢早衰67例疗效观察[J].高原医学杂志,2009,19(3)：57.
[171]李小林,吴献群.中西医结合治疗卵巢早衰36例[J].现代中医药,2009,29(1)：24-25.
[172]李孔益,彭清慧.中西医结合治疗卵巢早衰36例观察[J].实用中医药杂志,2009,25(11)：749-750.
[173]马晓玲.滋卵汤结合人工周期治疗高海拔地区卵巢早衰75例[J].陕西中医,2009,30(11)：1455-1456.
[174]王利平.补肾祛瘀法治疗卵巢功能早衰48例[J].陕西中医,2010,31(3)：264-265.
[175]宁艳,林琼霞,单志群,等.补肾益冲丸治疗肾虚型卵巢早衰患者的临床观察[J].河北医学,2010,16(2)：129-132.
[176]高翠霞.补肾活血、疏肝健脾法治疗卵巢早衰38例[J].河南中医,2010,30(11)：1098-1099.
[177]王慧民,朱雪梨,胡丽莎.补肾活血法对卵巢早衰免疫因素干预的临床观察[J].江西医药,2010,45(12)：1172-1174.
[178]叶亚智,韩连玉,张涛,等.抗卵衰冲剂治疗卵巢早衰患者抗卵巢抗体阳性45例疗效观察[J].河北中医,2010,32(4)：515-516.
[179]赵仁霞.二仙汤加味治疗卵巢早衰临床观察[J].中国中医药信息杂志,2010,17(1)：62-63.
[180]梁卓,王昕,刘宇新.抗衰复巢汤治疗卵巢早衰临床观察[J].辽宁中医杂志,2010,37(10)：1978-1979.
[181]丁青,吴紫玉,聂玲.护卵汤治疗心肾不交型卵巢早衰的临床观察[J].湖南中医药大学学报,2010,30(9)：184-186.
[182]黎志远,杨贤海,李天春,等.疏肝化瘀益气补肾法联合热敏灸治疗卵巢早衰62例临床观察[J].四川中医,2010,28(12)：86-88.
[183]徐华.坤泰胶囊联合雌孕激素序贯疗法治疗卵巢早衰临床分析[J].中国初级卫生保健,2010,24(9)：60-70.
[184]谷雨,谷志国.四二五合方治疗卵巢早衰40例临床观察[J].长春中医药大学学报,2010,26(3)：409.
[185]曹毅君,谭洁,戴洁.中西医结合治疗卵巢功能早衰疗效分析[J].中华全科医学,2010,8(11)：1411-1412.
[186]伍朝霞,李春娣,张立恒.益肾活血汤口服配合按摩治疗卵巢早衰59例[J].辽宁中医杂志,2010,37(8)：1533-1534.
[187]刘丽清,郭树榜,刘雁,等.中西医结合治疗卵巢早衰30例临床观察[J].山西中医,2010,26(7)：39-40.
[188]韦艳萍,赵苏萍,李远珺,等.左归丸联合艾灸治疗卵巢早衰的临床研究[J].右江医学,2010,38(2)：168-170.
[189]朱黎莉.中西医结合治疗卵巢早衰48例临床观察[J].临床医药实践,2009,8(5)：387-388.
[190]谢亚莉,王忠英,杨帆.中药复方治疗卵巢早衰39例临床观察[J].辽宁中医杂志,2010,37(12)：2359-2360.
[191]张华军,李雪莲.中医药综合疗法治疗卵巢早衰36例临床研究[J].中国中医药现代远程教育,2010,8(17)：48-49.
[192]左雨秀治.当归药理实验研究[J].医学生物学,1982,104(3)：159.
[193]周金黄,王药默.中药药理学[M].上海：上海科学出版社,1986：267.
[194]高向东.五种抗衰老中药对小鼠T-淋巴细胞增殖与IL-2产生的影响[J].中国 药科大学报,1990,21(1)：43.
[195]秦达念.菟丝子黄酮对实验动物及人绒毛组织生殖功能的影响[J].中药新药与临床药理,2000,11(6)：349-351.
[196]金治萃,贾彦彬,王晓立.山植、枸杞煎剂对红细胞免疫功能的影响[J].包头医学院学报,1997,13(1)：8-9.
[197]刘艳红,赵胜利,石瑞如.黄芪、枸杞对衰老大鼠血浆LPO、SOD及某些激素的影响[J].中药药理与临床,1996,12(2)：20-22.
[198]李炳如,佘运初.补肾对下丘脑-垂体-性腺轴功能的影响[J].中医杂志,1984,25(7)：63-64.
[199]卞以洁.仙灵脾对M受体-cGMP系统的调节作用[J].中国中药与临床,1988,(3)：29.
[200]王永祥,陈敏珠,徐淑云.白芍总甙的镇痛作用[J].中国药理学与毒理学杂志,1988,2(1)：6.
[201]明·万全.万氏女科[M].北京：中国中医药出版社,1998：363.
[202]宋·陈素庵.陈素庵妇科补解[M].上海：上海科学技术出版社,1983：170.